利妥昔单抗诱发一名多发性硬化症患者发生细胞因子释放综合征：病例报告。
Rituximab induced cytokine release syndrome in an MS patient: A case report.
作者信息
Etemadifar Masoud, Salari Mehri, Saeri Mahdieh, Sigari Amirhossein Akhavan, Ebrahimi Pelarti Sara
机构信息
Department of Neurosurgery Alzahra University Hospital Isfahan University of Medical Sciences Isfahan Iran.
Functional Neurosurgery Research Center Shohada Tajrish Comprehensive Neurosurgical Center of Excellence Shahid Beheshti University of Medical Sciences Tehran Iran.
出版信息
Clin Case Rep. 2021 Jul 9;9(7):e04407. doi: 10.1002/ccr3.4407. eCollection 2021 Jul.
Cytokine release syndrome with rituximab has been reported in certain diseases, however, it is rarely reported in MS patients treated with rituximab. The treating physician should suspect the syndrome when typical signs and symptoms appear.
使用利妥昔单抗时细胞因子释放综合征在某些疾病中已有报道，然而，在接受利妥昔单抗治疗的多发性硬化症患者中很少有报道。当出现典型的体征和症状时，治疗医生应怀疑该综合征。
Zotero 插件